2021
DOI: 10.1093/jac/dkab308
|View full text |Cite
|
Sign up to set email alerts
|

Prediction of ceftriaxone MIC inNeisseria gonorrhoeae usingDNA microarray technology and regression analysis

Abstract: Background Decreased susceptibility of Neisseria gonorrhoeae to extended-spectrum cephalosporins is a major concern. Elucidation of the phenotypic and genetic characteristics of such isolates is a priority task. Methods We developed a method for predicting the N. gonorrhoeae ceftriaxone susceptibility level (MICcro) by identifying genetic determinants of resistance using low-density hydrogel microarrays and a regression equat… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

0
9
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
7
1

Relationship

2
6

Authors

Journals

citations
Cited by 10 publications
(9 citation statements)
references
References 35 publications
0
9
0
Order By: Relevance
“…To date, a few isolates with chromosomal resistance to cephalosporins have been described. The typical ceftriaxone MICs for such isolates are 0.5–1.0 mg/L ( Młynarczyk-Bonikowska et al, 2020 ; Shaskolskiy et al, 2021 ). However, the emergence of ESBLs that can hydrolyze cephalosporins may lead to a several fold increase in the ceftriaxone MIC.…”
Section: Discussionmentioning
confidence: 99%
“…To date, a few isolates with chromosomal resistance to cephalosporins have been described. The typical ceftriaxone MICs for such isolates are 0.5–1.0 mg/L ( Młynarczyk-Bonikowska et al, 2020 ; Shaskolskiy et al, 2021 ). However, the emergence of ESBLs that can hydrolyze cephalosporins may lead to a several fold increase in the ceftriaxone MIC.…”
Section: Discussionmentioning
confidence: 99%
“…Notably, no cases of ineffective treatment of gonococcal infection with ceftriaxone have been recorded in Russia to date [13,24,25]. However, the identification of clinical isolates with mutations that reduce susceptibility to ceftriaxone emphasizes the need for continuous monitoring of N. gonorrhoeae antimicrobial susceptibility, particularly monitoring using the developed hydrogel droplet microarrays.…”
Section: Discussionmentioning
confidence: 99%
“…Targeted gene sequencing based on the Ion AmpliSeq™ platform (Thermo Fischer Scientific, Waltham, MA, USA) or AmpliSeq for Illumina products can be used for accurate genotyping of antimicrobial resistance determinants. An alternative technology that has successfully been proven useful for simultaneous identification of multiple specific genomic targets is matrix oligonucleotide microarray analysis, which is currently widely used [11][12][13][14].…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…Targeted gene sequencing based on the Ion AmpliSeq™ platform (Thermo Fischer Scientific, USA) or AmpliSeq for Illumina products can be used for accurate genotyping of antimicrobial resistance determinants. An alternative technology that has successfully been proven useful for simultaneous identification of multiple specific genomic targets is matrix oligonucleotide microarray analysis, which is currently widely used [11][12][13][14].…”
Section: Introductionmentioning
confidence: 99%